- Home
- AR vs TECH Comparison
AR vs TECH Comparison
Compare AR & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AR | TECH |
|---|---|---|
| Founded | 2002 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 9.2B |
| IPO Year | 2013 | 1989 |
Fundamental Metrics
Financial Performance| Metric | AR | TECH |
|---|---|---|
| Price | $34.26 | $59.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 14 |
| Target Price | $44.35 | ★ $71.23 |
| AVG Volume (30 Days) | ★ 4.9M | 1.6M |
| Earning Date | 02-11-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.54% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.87 | 0.49 |
| Revenue | ★ $5,007,754,000.00 | $1,216,732,000.00 |
| Revenue This Year | $24.23 | $2.33 |
| Revenue Next Year | $20.43 | $7.05 |
| P/E Ratio | ★ $18.31 | $122.55 |
| Revenue Growth | ★ 17.21 | 3.85 |
| 52 Week Low | $29.10 | $46.01 |
| 52 Week High | $44.02 | $79.28 |
Technical Indicators
Market Signals| Indicator | AR | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 48.39 | 50.87 |
| Support Level | $33.87 | $58.54 |
| Resistance Level | $35.63 | $59.64 |
| Average True Range (ATR) | 0.96 | 1.46 |
| MACD | -0.08 | 0.11 |
| Stochastic Oscillator | 46.54 | 80.40 |
Price Performance
Historical ComparisonAbout AR Antero Resources Corporation
Antero Resources, based in Denver, explores for and produces natural gas and natural gas liquids in the United States and Canada. At the end of 2024, the company reported proven reserves of 17.9 trillion cubic feet of natural gas equivalent. Production averaged approximately 3,424 million cubic feet of equivalent a day in 2024 at a ratio of 35% liquids and 65% natural gas.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.